SEATTLE, Oct. 04, 2024 (GLOBE NEWSWIRE) -- (OTC Pink: KANT) , a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune ...

Personal branding is about showing up and delivering value, and meetings—especially virtual ones—are a prime opportunity to ...

Tired of spending hours on presentations? Discover the best AI presentation makers to create stunning visuals effortlessly.

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that five abstracts have been accepted for e-Poster ...

Although breast cancer is the most common non-skin cancer diagnosed in women, finding support during treatment and through ...

ClearB Therapeutics, Inc., a company developing therapeutic vaccines designed to drive a functional cure for Hepatitis B, announced today that the com ...

Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases ...

Arbutus Biopharma Corporation (Nasdaq: ABUS) is poised to present significant findings on imdusiran, its RNAi therapeutic, ...

SketchBubble services big corporates such as Adobe, IBM, HP, Toyota, Mercedes-Benz, Volvo and Vodafone and claims to have ...

NKGen Biotech Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative ...